Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nls Pharmaceutics Ltd (NQ: NLSP )

0.1167 -0.0079 (-6.34%)
Streaming Delayed Price Updated: 2:39 PM EDT, Jun 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 328,112
Open 0.1272
Bid (Size) 0.1167 (6)
Ask (Size) 0.1168 (5)
Prev. Close 0.1246
Today's Range 0.1153 - 0.1272
52wk Range 0.1112 - 1.530
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists (DOXA)
Via ACCESSWIRE
NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol’s Neuroprotective Effects in Narcoleptic-like Rat Model
Via ACCESSWIRE

Performance

YTD
-80.15%
-80.15%
1 Month
-16.94%
-16.94%
3 Month
-65.82%
-65.82%
6 Month
-72.23%
-72.23%
1 Year
-87.84%
-87.84%

More News

Read More
NLS Pharmaceutics Announces Receipt of Additional Staff Delisting Determination from Nasdaq
Via ACCESSWIRE
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
Via ACCESSWIRE
NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering
Via ACCESSWIRE
NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering
Via ACCESSWIRE
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
Via ACCESSWIRE
NLS Pharmaceutics to Participate in the BIO-EUROPE Springtime Partnering Event
Via ACCESSWIRE
Nasdaq Accepts NLS Pharmaceutics’ Plan to Regain Listing Compliance
Via ACCESSWIRE
NLS Pharmaceutics Submits Plan to Regain Listing Compliance With Nasdaq
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Notice of Deficiency with Nasdaq Continued Listing Requirements
Via ACCESSWIRE
NLS Pharmaceutics CEO Issues Letter to Shareholders
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Spotify Layoffs 2023: What to Know About the Latest SPOT Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
Evercore ISI Is Souring on Fisker (FSR) Stock
Via InvestorPlace
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Is Garden Stage (GSIW) Stock Down 38% Today?
Via InvestorPlace
Why Is NLS Pharmaceutics (NLSP) Stock Down 24% Today?
Via InvestorPlace
Why Hawaiian Airlines Shares Are Trading Higher By Over 180%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
NLS Pharmaceutics Announces Exclusive Option Agreement to Develop and Commercialize Next Generation Dual Orexin Agonist Platform of Aexon Labs, Inc.
Via ACCESSWIRE
NLS Pharmaceutics Announces Election of Additional Board Members
Via ACCESSWIRE
NLS Pharmaceutics to Participate in the Oppenheimer Sleep Disorders Summit: Deep Dive into Narcolepsy and Idiopathic Hypersomnia
Via ACCESSWIRE
Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.